Tag: 22nd Century Group Inc (NYSEAMERICAN: XXII)

Business

22nd Century Group Inc (NYSEAMERICAN: XXII) Incorporates Strategic Partnerships to Facilitate Next-Generation Commercial Hemp/Cannabis Plant Breeding and Commercial Scale-Up

by 0 comments

22nd Century Group Inc (NYSEAMERICAN: XXII) has pronounced the addition of more strategic partnerships. It is a business decision to cooperate with expert commercial-scale plant breeders Folium Botanical and Sawatch Agriculture. Analysts applaud the company’s collaboration with the two northern hemisphere breeders, outlining that it will help improve 22nd Century’s breeding […]

Continue Reading →
Business

22nd Century Group Inc (NYSEAMERICAN: XXII) Pronounces The Restructuring Of Its Panacea Investment

by 0 comments

22nd Century Group Inc (NYSEAMERICAN: XXII) entered a definitive agreement that will support its restructuring moves. It shifts its focus to Panacea Life Sciences, Inc, and hopes to undertake several strategic investments moves as provided by the agreement. It considers the latest move to be a part of its grand scheme […]

Continue Reading →